Fortress Biotech
Stock Forecast, Prediction & Price Target
Fortress Biotech Financial Estimates
Fortress Biotech Revenue Estimates
Fortress Biotech EBITDA Estimates
Fortress Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $68.79M N/A | $75.74M 10.10% | $84.51M 11.57% | Avg: $125.95M Low: $122.17M High: $129.73M avg. 49.03% | Avg: $168.12M Low: $154.74M High: $180.46M avg. 33.48% | Avg: $196M Low: $180.39M High: $210.38M avg. 16.57% | |
Net Income
% change YoY
| $-164.82M N/A | $-213.91M -29.78% | $-60.63M 71.65% | Avg: $-75.78M Low: $-33.74M High: $-20.76M avg. -24.98% | Avg: $-74.52M Low: $-30.09M High: $-16.22M avg. 1.66% | Avg: $-26.84M Low: $-29.40M High: $-24.06M avg. 63.97% | |
EBITDA
% change YoY
| $-178.35M N/A | $-200.86M -12.62% | $-133.64M 33.46% | Avg: $-125.95M Low: $-129.73M High: $-122.17M avg. 5.75% | Avg: $-168.12M Low: $-180.46M High: $-154.74M avg. -33.48% | Avg: $-196M Low: $-210.38M High: $-180.39M avg. -16.57% | |
EPS
% change YoY
| -$30.26 N/A | -$36.1 -19.29% | -$8.47 76.53% | Avg: -$3.21 Low: -$4.16 High: -$2.56 avg. 62.14% | Avg: -$2.86 Low: -$3.71 High: -$2 avg. 10.96% | Avg: -$3.31 Low: -$3.63 High: -$2.97 avg. -15.93% | |
Operating Expenses
% change YoY
| $215.70M N/A | $247.22M 14.61% | $200.19M -19.02% | Avg: $168.09M Low: $163.03M High: $173.13M avg. -16.03% | Avg: $224.37M Low: $206.51M High: $240.83M avg. 33.48% | Avg: $261.56M Low: $240.74M High: $280.76M avg. 16.57% | |
FAQ
What is Fortress Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 13.55% in 2025-2027.
We have gathered data from 2 analysts. Their low estimate is -33.74M, average is -75.78M and high is -20.76M.
What is Fortress Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 33.03% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is $122.17M, average is $125.95M and high is $129.73M.
What is Fortress Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.05% in 2025-2027.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$4.16, average is -$3.21 and high is $-2.56.